Registered entities
Valink Therapeutics Inc
Reg. No. 4383316United States
LILIUMX LTD.
Reg. No. 13077801United Kingdom
Innovation
5 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 47 times.
| Year | Filings |
|---|---|
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Investor mix
13 investors on record; lead investors include Redalpine.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 92% |
| Accelerator & incubator | 1 | 8% |